GZB: Stimulator, Spinal-Cord, Implanted (Pain Relief)

Product code GZB, “Stimulator, Spinal-Cord, Implanted (Pain Relief)” in FDA's classification database, is a Class II device type under 21 CFR 882.5880 (implanted spinal cord stimulator for pain relief), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 139 clearances under GZB, 26 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
GZB
Regulation
21 CFR 882.5880
Class
II
Panel
Neurology
Clearances
139
Most recent
Aug 23, 2024
Third-party review
Not eligible
Implant
Yes

What it covers

An implanted spinal cord stimulator for pain relief is a device that is used to stimulate electrically a patient's spinal cord to relieve severe intractable pain. The stimulator consists of an implanted receiver with electrodes that are placed on the patient's spinal cord and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.

The identification in 21 CFR 882.5880, implanted spinal cord stimulator for pain relief. FDA gives GZB no definition of its own, so the regulation’s describes it.

FDA flags GZB devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K233801Nalu Neurostimulation System for Spinal Cord Stimulation; Nalu Neurostimulation System for Peripheral Nerve StimulationBoston Scientific NeuromodulationAug 23, 2024Traditional
K221376Nalu Neurostimulation SystemBoston Scientific NeuromodulationJun 10, 2022Special
K203547Nalu Neurostimulation SystemBoston Scientific NeuromodulationMar 25, 2021Traditional
K202274Nalu Neurostimulation Kit (lnte:gmted 40 em: Single 8/Dual 8), Nalu Neurostimulation Kit (Ported, 2 em: Single 8/Dual8), Dual 8 Ported Nalu Implantable Pulse Generator with 40 ern Kil, 40 cm/ 60 cm/60 em TrialJExtension Lead Kits, Patient Kits and miscellaneous replacement kitsBoston Scientific NeuromodulationNov 9, 2020Traditional
K201618Nalu Neurostimulation SCS systemBoston Scientific NeuromodulationJul 15, 2020Special
K191466SandShark Injectable Anchor (SIA) SystemStimwave Technologies, Inc.Nov 7, 2019Traditional
K190960Nalu Lead Blank (50cm)Boston Scientific NeuromodulationJul 11, 2019Traditional
K182720Freedom Spinal Cord Stimulator (SCS) SystemStimwave Technologies IncorporatedMar 29, 2019Traditional
K183047Nalu Neurostimulation SystemBoston Scientific NeuromodulationMar 22, 2019Traditional
K180981Stimulator Kit, Trial Kit, Spare Lead Kit, Wearable Assembly KitStimwave Technologies IncorporatedSep 19, 2018Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 139 with a free account)

Clearances by year

26 GZB 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
20241268
2022129
20211111
2020260
20194149
20181159
2017284
20162157
20152104
20142112
2013298
2012299
2011467

Who submits

7 applicants cleared a GZB device since 2011. 100% of the clearances went to applicants in United States. By type: Traditional 85% and Special 15%.

ApplicantClearances since 2011
Stimwave Technologies Incorporated8
Boston Scientific Neuromodulation7
Anulex Technologies, Inc.4
St Jude Medical3
St. Jude Medical Neuromodulation2
Anchor Innovation Medical (A.I.M.)1
Stimwave Technologies, Inc.1

How FDA classifies it

Class II (performance standards).

From 21 CFR 882.5880.

Standards

21 CFR 882.5880 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GZB clearances declared.

Ask about GZB

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about GZB

What is FDA product code GZB?

Product code GZB, “Stimulator, Spinal-Cord, Implanted (Pain Relief)” in FDA's classification database, is a Class II device type under 21 CFR 882.5880 (implanted spinal cord stimulator for pain relief), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 139 clearances under GZB, 26 of them since 2011.

How many 510(k) clearances are there under GZB?

FDA’s 510(k) database listed 139 clearances under GZB as of Oct 29, 2026, 26 of them decided since 2011; the most recent decision was Aug 23, 2024. The Predicate Finder searches the live database.

Which companies have the most GZB clearances?

Since 2011: Stimwave Technologies Incorporated (8), Boston Scientific Neuromodulation (7), Anulex Technologies, Inc. (4), St Jude Medical (3) and St. Jude Medical Neuromodulation (2). 7 applicants have cleared a GZB device in that time.

Sources

  1. FDA product classification: GZB · Product Classification database
  2. 21 CFR 882.5880: Implanted spinal cord stimulator for pain relief · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for GZB · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow GZBGet an email when FDA clears, recalls or publishes guidance for GZB devices.

Know what FDA already cleared.